\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 1
\BOOKMARK [1][-]{section.1.1}{A short history on chromosomes and DNA}{chapter.1}% 2
\BOOKMARK [1][-]{section.1.2}{Human genome variation}{chapter.1}% 3
\BOOKMARK [1][-]{section.1.3}{Conventional techniques for variant detection}{chapter.1}% 4
\BOOKMARK [1][-]{section.1.4}{Next-generation sequencing}{chapter.1}% 5
\BOOKMARK [1][-]{section.1.5}{Technical bias and error rates}{chapter.1}% 6
\BOOKMARK [1][-]{section.1.6}{DNA variant detection in genome diagnostics}{chapter.1}% 7
\BOOKMARK [2][-]{subsection.1.6.1}{Germline variants}{section.1.6}% 8
\BOOKMARK [2][-]{subsection.1.6.2}{Somatic variants}{section.1.6}% 9
\BOOKMARK [2][-]{subsection.1.6.3}{Prenatal testing}{section.1.6}% 10
\BOOKMARK [1][-]{section.1.7}{Aims of this thesis}{chapter.1}% 11
\BOOKMARK [2][-]{subsection.1.7.1}{PART 1: Germline variant detection \(chapters 2, 3 and 4\)}{section.1.7}% 12
\BOOKMARK [2][-]{subsection.1.7.2}{PART 2: Detection of somatic chromosomal translocations \(chapter 5\)}{section.1.7}% 13
\BOOKMARK [2][-]{subsection.1.7.3}{PART 3: Prenatal detection of trisomies \(chapters 6, 7 and 8\)}{section.1.7}% 14
\BOOKMARK [2][-]{subsection.1.7.4}{PART 4: Reflection and discussion \(Chapters 9, 10 and 11\)}{section.1.7}% 15
\BOOKMARK [0][-]{chapter.2}{targeted NGS can replace Sanger sequencing in clinical diagnostics}{}% 16
\BOOKMARK [1][-]{section.2.1}{Introduction}{chapter.2}% 17
\BOOKMARK [1][-]{section.2.2}{Material and Methods}{chapter.2}% 18
\BOOKMARK [2][-]{subsection.2.2.1}{Design of the Study}{section.2.2}% 19
\BOOKMARK [2][-]{subsection.2.2.2}{Patients/Samples}{section.2.2}% 20
\BOOKMARK [2][-]{subsection.2.2.3}{Targeted Enrichment Kit Design}{section.2.2}% 21
\BOOKMARK [2][-]{subsection.2.2.4}{Sample Preparation}{section.2.2}% 22
\BOOKMARK [2][-]{subsection.2.2.5}{Capturing/Enrichment}{section.2.2}% 23
\BOOKMARK [2][-]{subsection.2.2.6}{Sequencing}{section.2.2}% 24
\BOOKMARK [2][-]{subsection.2.2.7}{Data Analysis and Variant Annotation}{section.2.2}% 25
\BOOKMARK [2][-]{subsection.2.2.8}{Validation of Mutations by Sanger Sequencing}{section.2.2}% 26
\BOOKMARK [1][-]{section.2.3}{Results}{chapter.2}% 27
\BOOKMARK [2][-]{subsection.2.3.1}{Validation Phase}{section.2.3}% 28
\BOOKMARK [2][-]{subsection.2.3.2}{Application Phase}{section.2.3}% 29
\BOOKMARK [2][-]{subsection.2.3.3}{Reproducibility of Targeted NGS}{section.2.3}% 30
\BOOKMARK [1][-]{section.2.4}{Discussion}{chapter.2}% 31
\BOOKMARK [1][-]{section.2.5}{Conclusion}{chapter.2}% 32
\BOOKMARK [1][-]{section.2.6}{Acknowledgments}{chapter.2}% 33
\BOOKMARK [0][-]{chapter.3}{CoNVaDING: Single Exon Variation Detection in NGS data}{}% 34
\BOOKMARK [1][-]{section.3.1}{Introduction}{chapter.3}% 35
\BOOKMARK [1][-]{section.3.2}{Material and Methods}{chapter.3}% 36
\BOOKMARK [2][-]{subsection.3.2.1}{General Workflow CoNVaDING}{section.3.2}% 37
\BOOKMARK [2][-]{subsection.3.2.2}{Input Data}{section.3.2}% 38
\BOOKMARK [2][-]{subsection.3.2.3}{Control Group Selection}{section.3.2}% 39
\BOOKMARK [2][-]{subsection.3.2.4}{CNV Prediction Score Calculation}{section.3.2}% 40
\BOOKMARK [2][-]{subsection.3.2.5}{Quality Control Metrics}{section.3.2}% 41
\BOOKMARK [2][-]{subsection.3.2.6}{CNV Calling}{section.3.2}% 42
\BOOKMARK [2][-]{subsection.3.2.7}{Implementation of CoNVaDING}{section.3.2}% 43
\BOOKMARK [2][-]{subsection.3.2.8}{Validation of CoNVaDING}{section.3.2}% 44
\BOOKMARK [2][-]{subsection.3.2.9}{Comparison to CoNIFER, XHMM, and CODEX}{section.3.2}% 45
\BOOKMARK [1][-]{section.3.3}{Results}{chapter.3}% 46
\BOOKMARK [2][-]{subsection.3.3.1}{Validation of CoNVaDING}{section.3.3}% 47
\BOOKMARK [2][-]{subsection.3.3.2}{Comparison to CoNIFER, XHMM and CODEX}{section.3.3}% 48
\BOOKMARK [2][-]{subsection.3.3.3}{Performance of CoNVaDING on Low-Coverage Data}{section.3.3}% 49
\BOOKMARK [1][-]{section.3.4}{Discussion}{chapter.3}% 50
\BOOKMARK [1][-]{section.3.5}{Acknowledgments}{chapter.3}% 51
\BOOKMARK [0][-]{chapter.4}{Genetic test to detect translocations in acute leukemia using TLA}{}% 52
\BOOKMARK [1][-]{section.4.1}{Introduction}{chapter.4}% 53
\BOOKMARK [1][-]{section.4.2}{Material and Methods}{chapter.4}% 54
\BOOKMARK [2][-]{subsection.4.2.1}{Patient bone marrow cells and cell lines}{section.4.2}% 55
\BOOKMARK [2][-]{subsection.4.2.2}{TLA acute leukemia gene panel}{section.4.2}% 56
\BOOKMARK [2][-]{subsection.4.2.3}{Multiplex TLA methods}{section.4.2}% 57
\BOOKMARK [2][-]{subsection.4.2.4}{Routine genetic and cytogenetic methods}{section.4.2}% 58
\BOOKMARK [2][-]{subsection.4.2.5}{Validation of the multiplex TLA method}{section.4.2}% 59
\BOOKMARK [1][-]{section.4.3}{Results}{chapter.4}% 60
\BOOKMARK [2][-]{subsection.4.3.1}{Validation of the TLA multiplex panel - Training set}{section.4.3}% 61
\BOOKMARK [2][-]{subsection.4.3.2}{Validation of the TLA multiplex panel - Test set}{section.4.3}% 62
\BOOKMARK [1][-]{section.4.4}{Discussion}{chapter.4}% 63
\BOOKMARK [1][-]{section.4.5}{Acknowledgments}{chapter.4}% 64
\BOOKMARK [1][-]{section.4.6}{Online data supplement}{chapter.4}% 65
\BOOKMARK [0][-]{chapter.5}{Novel algorithms for improved sensitivity in NIPT}{}% 66
\BOOKMARK [1][-]{section.5.1}{Introduction}{chapter.5}% 67
\BOOKMARK [1][-]{section.5.2}{Material and Methods}{chapter.5}% 68
\BOOKMARK [2][-]{subsection.5.2.1}{Chi-squared-based variation reduction}{section.5.2}% 69
\BOOKMARK [2][-]{subsection.5.2.2}{Regression-based Z-score}{section.5.2}% 70
\BOOKMARK [2][-]{subsection.5.2.3}{Match QC score}{section.5.2}% 71
\BOOKMARK [2][-]{subsection.5.2.4}{Validation of algorithms}{section.5.2}% 72
\BOOKMARK [1][-]{section.5.3}{Results}{chapter.5}% 73
\BOOKMARK [2][-]{subsection.5.3.1}{Effect of peak correction}{section.5.3}% 74
\BOOKMARK [2][-]{subsection.5.3.2}{Effects of the two GC correction methods}{section.5.3}% 75
\BOOKMARK [2][-]{subsection.5.3.3}{Effect of chi-squared-based variation reduction}{section.5.3}% 76
\BOOKMARK [2][-]{subsection.5.3.4}{Effect of trisomy prediction algorithms}{section.5.3}% 77
\BOOKMARK [2][-]{subsection.5.3.5}{Match QC score}{section.5.3}% 78
\BOOKMARK [1][-]{section.5.4}{Discussion}{chapter.5}% 79
\BOOKMARK [1][-]{section.5.5}{Supplementary material}{chapter.5}% 80
\BOOKMARK [1][-]{section.5.6}{Supplement 1: 2VR for chromosome 21}{chapter.5}% 81
\BOOKMARK [1][-]{section.5.7}{Supplement 3: Regression model for chromosome 13}{chapter.5}% 82
\BOOKMARK [0][-]{chapter.6}{NIPTeR: an R package for NIPT analysis}{}% 83
\BOOKMARK [1][-]{section.6.1}{Background}{chapter.6}% 84
\BOOKMARK [1][-]{section.6.2}{Implementation}{chapter.6}% 85
\BOOKMARK [1][-]{section.6.3}{Results}{chapter.6}% 86
\BOOKMARK [2][-]{subsection.6.3.1}{Workflow}{section.6.3}% 87
\BOOKMARK [2][-]{subsection.6.3.2}{Prediction and control group statistics}{section.6.3}% 88
\BOOKMARK [2][-]{subsection.6.3.3}{Quality control}{section.6.3}% 89
\BOOKMARK [2][-]{subsection.6.3.4}{Performance}{section.6.3}% 90
\BOOKMARK [1][-]{section.6.4}{Conclusion}{chapter.6}% 91
\BOOKMARK [1][-]{section.6.5}{Availability and requirements}{chapter.6}% 92
\BOOKMARK [1][-]{section.6.6}{Additional files}{chapter.6}% 93
\BOOKMARK [0][-]{chapter.7}{NIPTRIC: a tool for clinical interpretation of NIPT results}{}% 94
\BOOKMARK [1][-]{section.7.1}{Introduction}{chapter.7}% 95
\BOOKMARK [1][-]{section.7.2}{Results}{chapter.7}% 96
\BOOKMARK [2][-]{subsection.7.2.1}{Performance of the PPR calculator}{section.7.2}% 97
\BOOKMARK [1][-]{section.7.3}{Discussion}{chapter.7}% 98
\BOOKMARK [1][-]{section.7.4}{Material and Methods}{chapter.7}% 99
\BOOKMARK [2][-]{subsection.7.4.1}{The PPR calculator}{section.7.4}% 100
\BOOKMARK [2][-]{subsection.7.4.2}{A priori risk}{section.7.4}% 101
\BOOKMARK [2][-]{subsection.7.4.3}{Z-score}{section.7.4}% 102
\BOOKMARK [2][-]{subsection.7.4.4}{Percentage of foetal DNA}{section.7.4}% 103
\BOOKMARK [2][-]{subsection.7.4.5}{Coefficient of variation}{section.7.4}% 104
\BOOKMARK [2][-]{subsection.7.4.6}{Examples of the use of the PPR calculator}{section.7.4}% 105
\BOOKMARK [2][-]{subsection.7.4.7}{Performance of the PPR calculator}{section.7.4}% 106
\BOOKMARK [0][-]{section*.77}{Bibliography}{}% 107
\BOOKMARK [0][-]{section*.78}{List of Tables}{}% 108
\BOOKMARK [0][-]{section*.79}{List of Figures}{}% 109
